These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14613360)

  • 1. Analysis of a prescription drug prior authorization program in a Medicaid health maintenance organization.
    LaPensee KT
    J Manag Care Pharm; 2003; 9(1):36-44. PubMed ID: 14613360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study.
    Law MR; Lu CY; Soumerai SB; Graves AJ; LeCates RF; Zhang F; Ross-Degnan D; Adams AS
    Clin Ther; 2010 Apr; 32(4):729-41; discussion 716. PubMed ID: 20435243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC; Marcoux RM; Quilliam BJ
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a pharmacy benefit to a managed Medicaid population.
    Smith WW; Perry SC
    Med Interface; 1995 Dec; 8(12):84-7, 97. PubMed ID: 10153524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care.
    Abraham AJ; Andrews CM; Harris SJ; Westlake MM; Grogan CM
    JAMA Health Forum; 2022 Nov; 3(11):e224001. PubMed ID: 36331441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spillover effects of state medicaid antipsychotic prior authorization policies in US commercially insured youth.
    Spence O; Reeves G; dosReis S
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1064-1071. PubMed ID: 32558177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.
    Farley JF; Cline RR; Schommer JC; Hadsall RS; Nyman JA
    Clin Ther; 2008 Aug; 30(8):1524-39; discussion 1506-7. PubMed ID: 18803994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit restrictions and gout treatment.
    Wang SM; Aranda GA; Gao S; Patel BV
    J Manag Care Pharm; 2013; 19(9):773-82. PubMed ID: 24156646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study.
    Lu CY; Law MR; Soumerai SB; Graves AJ; LeCates RF; Zhang F; Ross-Degnan D; Adams AS
    Clin Ther; 2011 Jan; 33(1):135-44. PubMed ID: 21397779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid.
    Melvin KE; Hart JC; Sorvig RD
    Psychiatr Serv; 2017 Oct; 68(10):1061-1067. PubMed ID: 28566023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population.
    Hartung DM; Touchette DR; Ketchum KL; Haxby DG; Goldberg BW
    Clin Ther; 2004 Sep; 26(9):1518-32. PubMed ID: 15531015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior authorization to manage drug utilization and costs.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(1):95. PubMed ID: 14613376
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacoeconomic modeling of prior-authorization intervention for COX-2 specific inhibitors in a 3-tier copay plan.
    Stacy J; Shaw E; Arledge MD; Howell-Smith D
    J Manag Care Pharm; 2003; 9(4):327-34. PubMed ID: 14613451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Florida Medicaid's State-Mandated Formulary Provision on Prescription Drug Use and Health Plan Costs in a Medicaid Managed Care Plan.
    Munshi KD; Mager D; Ward KM; Mischel B; Henderson RR
    J Manag Care Spec Pharm; 2018 Feb; 24(2):124-131. PubMed ID: 29384030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of health care experiences for medicaid and commercially enrolled children in a large, nonprofit health maintenance organization.
    Newacheck PW; Lieu T; Kalkbrenner AE; Chi FW; Ray GT; Cohen JW; Weinick RM
    Ambul Pediatr; 2001; 1(1):28-35. PubMed ID: 11888369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.